Related Experiment Video

Updated: Jan 4, 2026

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

24.9K

Multiple Organ Dysfunction During Therapeutic Cooling of Asphyxiated Infants

Indira Bhagat1, Subrata Sarkar2

  • 1Division of Neonatal-Perinatal Medicine, Wayne State University, Children's Hospital of Michigan, Detroit, MI.

Neoreviews
|November 3, 2019
PubMed

Insights

Therapeutic cooling protects infants with hypoxic-ischemic encephalopathy. Proper management of organ system complications during cooling is crucial for improved outcomes in these newborns.

Area of Science:

  • Neonatal physiology
  • Therapeutic hypothermia
  • Neurology

Background:

  • Hypoxic-ischemic encephalopathy (HIE) affects newborns due to oxygen deprivation.
  • Therapeutic cooling is a standard neuroprotective treatment for HIE.
  • HIE can lead to multi-organ system complications.

Purpose of the Study:

  • To review the physiological effects of therapeutic cooling in asphyxiated infants.
  • To discuss the management of organ system complications during neonatal cooling.

Main Methods:

  • Literature review of studies on therapeutic cooling in neonates.
  • Analysis of physiological changes and complications associated with cooling protocols.

Main Results:

  • Cooling impacts multiple organ systems in asphyxiated infants.
  • Specific physiological alterations require careful monitoring and management.
  • Current cooling ranges necessitate comprehensive care strategies.

Conclusions:

  • Effective neuroprotection requires managing cooling-induced physiological changes.
  • A multidisciplinary approach is essential for optimizing outcomes in infants undergoing therapeutic cooling.

More Related Videos

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

12.3K
Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms05:00

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms

Published on: March 3, 2021

3.2K

Related Concept Videos

Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
969
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
536